New Information Reveals Opportunity in Volatility: New Reports on Lorillard, Mead Johnson, Medifast, Michael Kors, and Movado Group

NEW YORK, December 31, 2014 /PRNewswire/ --

Moments ago, Analysts Review released new research updates concerning several important developing situations including Lorillard (NYSE: LO), Mead Johnson (NYSE: MJN), Medifast (NYSE: MED), Michael Kors (NYSE: KORS), and Movado Group (NYSE: MOV). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.

To access our full PDF reports on a complementary basis, please visit the links below.

--

Today's update concerns the following companies:

============

Full PDF Download Links (you may have to copy and paste the following links into your browser):

LO Research Report: ( http://get.analystsreview.com/pdf/?c=Lorillard&d=31-Dec-2014&s=LO ),

MJNResearch Report: ( http://get.analystsreview.com/pdf/?c=Mead%20Johnson&d=31-Dec-2014&s=MJN ),

MEDResearch Report: ( http://get.analystsreview.com/pdf/?c=Medifast&d=31-Dec-2014&s=MED ),

KORS Research Report: ( http://get.analystsreview.com/pdf/?c=Michael%20Kors&d=31-Dec-2014&s=KORS ),

MOV Research Report: ( http://get.analystsreview.com/pdf/?c=Movado%20Group&d=31-Dec-2014&s=MOV ).

============

--

Analyst Update: Financial Results, Dividend Declaration, Recognitions, Licensing Agreement, and Leadership Changes

Reviewed by: Rohit Tuli, CFA®  

The U.S. stock market ended in red on Tuesday with energy stocks being the worst performers of the day. A less than expected December 2014 consumer confidence index (CCI) figure deterred investor confidence further. The U.S. CCI climbed to 92.6 in December from a revised 91.0 last month, below a post-recession high of 94.1 set in October 2014. The DJIA declined 0.31%, S&P 500 dropped 0.49% and the Nasdaq Composite weakened 0.61% during the session. The European stock market also declined, led by weakness in energy companies as Brent oil fell to a five and a half year low on persistent concerns about a global supply glut. The Asian stock market closed broadly lower too. The Japanese government on Tuesday agreed to a tax reform, approving a plan to cut corporate taxes by 2.51 percentage point from April 2015 and then by another 0.78 percentage points in the following year, in an effort to spur economic growth.

Lorillard, Inc. (Lorillard) reported diluted EPS of $0.80 in Q3 2014, representing an increase of 15.9% YoY and $2.37 for 9M 2014, registering a YoY decline of 0.4%. The Company's net sales for Q3 2014 totaled $1.8 billion, up marginally, due to a 1.6% increase in net sales of cigarettes, partially offset by a decrease in net sales of electronic cigarettes.

Mead Johnson Nutrition Company (Mead Johnson) announced that its Board of Directors has declared a regular quarterly common stock dividend of $0.375 per share for the quarter ending December 31, 2014, which will be paid on January 2, 2015, to shareholders of record at close of business on December 15, 2014.

Medifast, Inc. (Medifast) announced that Barry B. Bondroff, Lead Director on the Company's Board of Directors, has become a National Association of Corporate Directors (NACD) fellow. A Director on Medifast's Board since 2008, Bondroff also serves as a member of Medifast's Audit Committee, Executive Committee, and Mergers & Acquisitions Committee.

Michael Kors Holdings Limited (Michael Kors) and Fossil Group, Inc. announced the renewal of their global licensing agreement through 2024. In 2004, Michael Kors partnered with Fossil Group to design, develop and distribute watches under the Michael Kors label and the relationship expanded to encompass jewelry in 2010 and the companies are presently joining forces to develop the men's watch business.

Movado Group, Inc. (Movado Group) announced the addition of Jo An Lawson as General Manager of Wearable Devices, who will now be responsible for recognizing exclusive opportunities for the Company in the areas of technology, and developing strategic alliances, enabling the Company to introduce wearable device products consistent with its luxury product branding philosophy.

--

About Analysts Review  

At Analysts Review, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

Analysts Review was designed for investors. By providing the best information available, we have set ourselves apart as one of the premier online investor communities.

--

Editor Note: This is not company news. We are an independent source and our views do not reflect the companies mentioned.

Compliance Procedure: Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA®. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

Further Resources: For more information about this release including editorial notes, compliance procedures and legal disclosures, please visit: http://www.analystsreview.com/editors

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


SOURCE Analysts Review

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.